
Continuous Infusion Apomorphine Approved
On February 4, 2024, the United States Food and Drug Administration approved ONAPGO, a formulation of apomorphine designed for continuous infusion under the skin. ONAPGO was developed …
On February 4, 2024, the United States Food and Drug Administration approved ONAPGO, a formulation of apomorphine designed for continuous infusion under the skin. ONAPGO was developed …
Dyskinesia–the involuntary, uncontrolled, dance-like movements that many people with Parkinson’s experience–can affect any part of the body. When the muscles involved in breathing are impacted, it …
When you first begin taking Parkinson’s medications, you may find that they work so well that you rarely or never experience troublesome symptoms. As time passes, however, …
Today, the United States Food and Drug Administration approved the first continuous infusion carbidopa/levodopa system. The treatment, developed by Abbvie and called VYALEV, has been approved for …
In August 2024, the FDA approved a new Parkinson’s medication, CREXONT®. CREXONT, which was developed by Amneal, is a …